Skip to main content
. Author manuscript; available in PMC: 2021 Mar 24.
Published in final edited form as: Dig Dis Sci. 2019 Aug 12;65(2):524–533. doi: 10.1007/s10620-019-05760-x

Table 4.

Correlations of most recent MELD score with Clinical Parameters, Growth Factors and Vascular Injury Markers measured at an earlier time-point

Parameters (Time-Point A) MELD Score (Time-Point B)
r p n
Ishak fibrosis 0.55 0.0044* 25
PT-INR 0.63 0.0063* 17
VCAM1 0.45 0.0242* 25
P-Selectin −0.42 0.0351* 25
ICAM-3 0.41 0.0412* 25
TGFβ1 −0.39 0.0535 25
Platelets −0.40 0.0545 24
PDGFAA −0.38 0.058 25
PDGF-BB −0.38 0.0583 25
Albumin −0.36 0.0873 24
Direct bilirubin 0.35 0.0955 24
TM 0.32 0.1179 25
PP Inflammation 0.33 0.1202 23
AST 0.31 0.1472 24
Total bilirubin 0.22 0.3067 24
Total Inflammation 0.20 0.371 23
E-Selectin 0.16 0.4457 25
ALP 0.15 0.4883 24
ALT 0.14 0.5048 24
VEGF −0.13 0.5223 25
ICAM-1 0.13 0.5235 25

Correlations were calculated by Spearman’s rank correlation between MELD score from the most recent time-point (B) and biopsy scores, GFs and VIMs, and clinical parameters, measured from an earlier time-point (A) in the same patients. Spearman’s rank correlation coefficient, r (rho), p value, and n, number of data points for each variable, are shown above.

*

indicates statistical significance using p-values at a cut-off of <0.05.

PP: Periportal, ALT, alanine transaminase; AST, aspartate transaminase; ALP, alkaline phosphatase; PT-INR, prothrombin time international normalized ratio; MELD, Model for End stage Liver Disease, TM: Thrombomodulin.